Background: Data concerning idiopathic recurrent pericarditis in pregnancy are scarce. Objectives: To evaluate the management and outcome of idiopathic recurrent pericarditis during pregnancy. Methods and results: Twenty-one pregnancies were evaluated in fourteen women with a history of recurrent idiopathic pericarditis (mean maternal age 31.5 years, mean gestational age 39.0 weeks), and subdivided in 2 cohorts: eight pregnancies were analyzed retrospectively (2002−2010), thirteen (2011–2017) prospectively and followed according a predefined management protocol. Ten pregnancies were uneventful, three ended in spontaneous early abortion, one fetal death occurred at 19 weeks. Recurrences of pericarditis occurred in eight and were treated by adding NSAIDs in two cases; in five cases the dose of corticosteroids was increased and in two cases aspirin was started/increased; paracetamol was always allowed. Colchicine was used in two cases in the prospective cohort. HELLP syndrome occurred in one patient, which resolved after delivery, and one patient experienced arterial hypertension and elevated transaminase. All infants had a good outcome (mean birth weight 3114 g, 10 males). Birth weight was significantly lower in the retrospective cohort (respectively 2806 g vs. 3320 g, p-value 0.017) in which higher doses of corticosteroids were used (median dose respectively 10.0 mg vs. 2.5 mg, p-value 0.048). Five recurrences of pericarditis occurred after delivery, easily treated with standard therapy. Conclusion: General outcomes of pregnancy in patients with idiopathic recurrent pericarditis is good, especially when patients are carefully followed by multidisciplinary teams according to standardized protocols.

Management of idiopathic recurrent pericarditis during pregnancy / A. Brucato, N. Pluymaekers, E. Tombetti, S. Rampello, S. Maestroni, M. Lucianetti, A. Valenti, Y. Adler, M. Imazio. - In: INTERNATIONAL JOURNAL OF CARDIOLOGY. - ISSN 0167-5273. - 282(2019 May 01), pp. 60-65. [10.1016/j.ijcard.2019.02.003]

Management of idiopathic recurrent pericarditis during pregnancy

A. Brucato
Primo
;
E. Tombetti;
2019

Abstract

Background: Data concerning idiopathic recurrent pericarditis in pregnancy are scarce. Objectives: To evaluate the management and outcome of idiopathic recurrent pericarditis during pregnancy. Methods and results: Twenty-one pregnancies were evaluated in fourteen women with a history of recurrent idiopathic pericarditis (mean maternal age 31.5 years, mean gestational age 39.0 weeks), and subdivided in 2 cohorts: eight pregnancies were analyzed retrospectively (2002−2010), thirteen (2011–2017) prospectively and followed according a predefined management protocol. Ten pregnancies were uneventful, three ended in spontaneous early abortion, one fetal death occurred at 19 weeks. Recurrences of pericarditis occurred in eight and were treated by adding NSAIDs in two cases; in five cases the dose of corticosteroids was increased and in two cases aspirin was started/increased; paracetamol was always allowed. Colchicine was used in two cases in the prospective cohort. HELLP syndrome occurred in one patient, which resolved after delivery, and one patient experienced arterial hypertension and elevated transaminase. All infants had a good outcome (mean birth weight 3114 g, 10 males). Birth weight was significantly lower in the retrospective cohort (respectively 2806 g vs. 3320 g, p-value 0.017) in which higher doses of corticosteroids were used (median dose respectively 10.0 mg vs. 2.5 mg, p-value 0.048). Five recurrences of pericarditis occurred after delivery, easily treated with standard therapy. Conclusion: General outcomes of pregnancy in patients with idiopathic recurrent pericarditis is good, especially when patients are carefully followed by multidisciplinary teams according to standardized protocols.
Management; Outcome; Pericarditis; Pregnancy; Recurrent pericarditis; Therapy; Cardiology and Cardiovascular Medicine
Settore MED/09 - Medicina Interna
1-mag-2019
Article (author)
File in questo prodotto:
File Dimensione Formato  
Pregnancy Int J Cardiol 2019 1-s2.0-S0167527318371316-main.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 232.85 kB
Formato Adobe PDF
232.85 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
1-s2.0-S0167527318371316-main.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 308.03 kB
Formato Adobe PDF
308.03 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/630213
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 19
  • ???jsp.display-item.citation.isi??? 17
social impact